Making self-monitored blood pressure accessible for all pregnant and postpartum moms
The Need
As many as one in twelve pregnancies is affected by hypertension in its most dangerous form – preeclampsia. In some regions of the country 15-20% of pregnancies are affected. The current COVID-19 crisis has affected prenatal and postpartum obstetrics care. Regulations have been optimized for telehealth, and many in-person visits for prenatal and postpartum visits have been eliminated. This means that blood pressure screening, recommended throughout pregnancy[i], proteinuria assessments, and a review of signs and symptoms are hampered or missing for thousands of women each day. Racial disparities have been exacerbated during the COVID pandemic. This telehealth-friendly environment provides an excellent opportunity to improve patient-provider communications and maternal healthcare practices now and for the long-term. But only if women are given the tools and technology they need to actively participate in their healthcare.
As a first step to address the need for self-monitored blood pressure, the Preeclampsia Foundation started providing the Cuff Kit™ in June 2020 to women at highest risk of developing preeclampsia and other hypertensive disorders of pregnancy – especially to our most vulnerable populations. The kit includes a validated automatic BP device, educational tools around signs and symptoms, postpartum risk, “How to take your own blood pressure” information sheet and video, BP log tracker, and additional evidence-based information online.
Check out one woman's story of how The Cuff Project helped her detect her own preeclampisa as featured on CNN Health.
Interested in providing the Cuff Kit™ to your patients?
Participating providers must be able to:
The Cuff Project: Our Strategic Plan
The ability for all women to access healthcare during and after pregnancy has been further challenged by COVID-19, but the application of home monitoring and telehealth as an important option has garnered considerable attention. Although the Cuff Kit is an important and urgent first step, accelerated by the COVID pandemic, our view of this solution extends beyond this emergency response. There is immediate need to fund projects related to this entire scope of work:
[i] JAMA. 2017;317(16):1661-1667. doi:10.1001/jama.2017.3439
[ii] Oral presentation at the 39th Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine, Las Vegas, NV, Feb 11-16, 2019. https://doi.org/10.1016/j.ajog.2019.05.011
[iii] Bello N. Hypertension. 2018;71:326-335. DOI: 10.1161/HYPERTENSIONAHA.117.10295
Nurses play a vital role in detecting preeclampsia and caring for patient before, during, and beyond pregnancy.
A Call-to-Action to Accelerate Development and Adoption of Biomarkers
Order our Ask About Aspirin Rack Card. Aspirin can prevent the formation of blood clots. This can make aspirin useful in treating or preventing some conditions like heart attacks and stroke...
Heart disease is the leading cause of death for women and appears to be increasing in women aged 35 to 54 years. Women who have had preeclampsia have three to four times the risk of high...
December 1, 2021 – Melbourne, FL – The Preeclampsia Foundation announced that its Cuff Kit™ program is a Phase 1 winner of the U.S. Department of Health and Human Services (HHS) Offi...
Educating Your Clients About Preeclampsia: A Doula Approach to Care Equity November 9, 2021 - Melbourne, FL – Doulas play a key role in helping pregnant patients navigate pregnancy, labor, deli...
The Preeclampsia Foundation is responding to the needs of pregnant and postpartum women, during COVID-19, with the introduction of The Cuff Kit™. With women’s obstetric care being mo...
High Blood Pressure During Pregnancy May Be a Warning Sign of Life-threatening Condition World’s Leading Clinicians and Researchers to Discuss Best Practices for Predicting, Preventing, and M...
September 25, 2020 – Melbourne, FL –– The Preeclampsia Foundation is urgently calling for the development of biomarker tests for simple, rapid, and accurate diagnosis and prediction...